Hologic, Inc.
NASDAQ Global Select•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Stephen P. MacMillan
- Full Time Employees
- 6,990
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 250 Campus Drive Marlborough MA United States of America 01752
- IPO Date
- Mar 1, 1990
- CIK
- 0000859737
- Website
- hologic.com
- Similar Companies
- Business
- Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Company News
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
Should You Bet on HOLX Stock This Breast Cancer Awareness Month?
Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
Hologic (HOLX) Stock Sinks As Market Gains: Here's Why
Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
HOLX Stock Gains From New Offerings Despite Macro Issues
Is HOLX Stock a Smart Hold for Your Portfolio Right Now?
Here's Why Hologic (HOLX) is a Strong Value Stock
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Why Hologic (HOLX) is a Top Value Stock for the Long-Term
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report?
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock